Greenlab aims to become a world leader in the research, development and cultivation of pharmaceutical grade medicinal cannabis compounds. Greenlab’s team of talented scientists, medical doctors and business professionals are dedicated to make Greenlab a world leader in Medicinal Cannabis.
Greenlab, founded in 2019, became the first New Zealand’s South Island based Company to be awarded a R&D licence in August 2019.
Greenlab aims to cultivate premium quality cannabis products for patients in New Zealand and across the world.
Greenlab has access to unique germplasm and is developing novel products through relationships with number of organisations within New Zealand and overseas.